Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs 5-FU with Chemoradiation in Resected Pancreatic Cancer
NCT00003216Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jul 1998
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by NRG Oncology. Started Jul 1998; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00003216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003216.